Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain

Status unconfirmed · Phase 2 · Has a placebo group

Conditions studied: Pegfilgrastim-induced Back and Leg Pain

In brief

The purpose of this study is to determine the incidence of pegfilgrastim-induced back and leg pain and to determine whether the antihistamine loratadine can prevent pegfilgrastim-induced back and leg pain.

Key facts

Study ID
NCT01311336
Run by
University of Vermont
People needed
55
Starts
2011-05-01
Expected to finish
2013-06-01
Last updated by the study team
2013-01-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.